A three-member technical committee comprising experts from premier ocean research institutions in the country has said the ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the ...

Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

BRAFTOVI's FDA Approval Sparks Hope for BRAF V600E-mutant Colorectal Cancer Patients and Sets Pfizer Up for Explosive Growth ...

Dr. Scott Kopetz discusses the BREAKWATER trial investigating Braftovi and Erbitux plus chemo in those with BRAF V600E+ ...

For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard ch ...

Design released for $4 million universal access fishing platform in BunburyAdjacent breakwater precinct to support needs of users, carers and visitors ...

Analysts expect the New York-based company to report quarterly earnings at 46 cents per share, up from 10 cents per share in ...

Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...

Work is underway to repair Workington's storm-damaged breakwater. The sea defences, located off the South Pier, were breached in two places by southwesterly storms, scattering concrete blocks onto the ...

Being evaluated for the treatment of metastatic colorectal cancer, the combination regimen achieved an objective response ...